O'Shaughnessy Asset Management, LLC Mersana Therapeutics, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$5.48 - $9.86 $3,567 - $6,418	-651 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$13.28 - $18.07 $39,999 - $54,426	-3,012 Reduced 82.23%	651 $9,000
Q4 2020 Feb 11, 2021	BUY	$16.84 - $27.59 $50,722 - $83,101	3,012 Added 462.67%	3,663 $97,000
Q2 2020 Aug 13, 2020	BUY	$5.24 - $23.4 $3,411 - $15,233	651 New	651 $15,000
Q1 2020 May 13, 2020	SELL	$4.41 - $9.28 $2,875 - $6,050	-652 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$1.45 - $6.73 $945 - $4,387	652 New	652 $4,000

130

104M

58.5K

471K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $56.4M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.